MAXIMIZING VALUE
​We work in various capacities to maximize product value and prepare your asset for a next stage gate – Geographical expansion / Approval for Funding / Sell. Our team will also help to set the risk appetite and expectations for your pharmaceutical product launch.
STAKEHOLDERS
OPERATIONAL
MANAGEMENT
APPROACH
• Mindset for your pharma product launch.
​
• Outcome-driven approach with clarity on accountability, milestones, facilitation and design.
​
• Disciplined thinking and putting the discipline into critical path activities for every stage gate through operationalization of governance across the operational teams.
​
• In depth review and analysis of selected regional/country dynamics and potential for the asset.
​
• Prioritization framework for go to market in selected regions.
​
• Developing process to determine the single source of truth regarding regulatory approval, product supply & launch dates.
KEY OUTCOMES
• The asset(s) positioned for optimal value with high confidence.
• Outcomes defined / operationalized.
SOLUTIONS
• We utilize a stage gate Asset Planning Framework to streamline critical activities, with additional risk register and mitigation solutions.
​
• As part of our pharmaceutical product management service, we will also develop a framework for geographical expansion prioritization and identify the key components of a successful launch for your product.
GOVERNANCE
Robust, repeatable, and documented processes, implemented based on data and insights in order to make governance simple and auditable.
DECISION MAKING
We will better equip teams to make the necessary decisions, helping you to take smart risks and be confident in your pathway.
FACILITATING SYNERGIES
Realize cross country synergy, and learn to use elevated processes to launch a new product. By learning on the job, we can support you to refine processes and meet your specific needs.
GROUNDED IN FOUR KEY PRINCIPLES:
1. Optimizing portfolio investment decisions
Making informed portfolio investment decisions by evaluating opportunities, risks, and returns to maximize ROI.
2. Enhancing asset value
Enhance asset value from multiple lenses and choose the right pathway in clinical development or go to market.
3. Developing an acceleration infrastructure
We facilitate speed to market by developing acceleration infrastructure that streamlines processes and reduces time to market, ensuring a competitive advantage.
4. Expanding access to patients
We help expand access to patients by designing strategies that address patient needs and preferences, ensuring equitable access to healthcare solutions.